-
Active Stocks: Akebia Therapeutics (NASDAQ:AKBA), LogMeIn (NASDAQ:LOGM), WageWorks (NYSE:WAGE), Microsoft Corporation (NASDAQ:MSFT), Headwaters Incorporated (NYSE:HW)
On Wednesday shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) closed at $8.25. On Apr 22, Akebia Therapeutics, Inc. (NASDAQ:AKBA) announced the closing of its public offering of 8,363,636 shares of common stock at a public offering price of $8.25 per share. This includes the exercise in full by the underwriters of their option to purchase 1,090,909…
-
Big Movers: General Electric Company (NYSE:GE), Akebia Therapeutics (NASDAQ:AKBA), G. Willi Food-International (NASDAQ:WILC), Rhino Resource Partners LP (NYSE:RNO), AEGON (NYSE:AEG)
On last trading day General Electric Company (NYSE:GE) moved up 0.30% to close at $26.88. Its volatility for the week is 1.29% while volatility for the month is 1.80%. GE’s sales growth for past 5 years was -0.80% and its EPS growth for past 5 years was 8.80%. General Electric Company (NYSE:GE) monthly performance is…
-
Top Wall Street Stories: Athersys (NASDAQ:ATHX), Coronado Biosciences (NASDAQ:CNDO), Green Plains Inc. (NASDAQ:GPRE), Akebia Therapeutics (NASDAQ:AKBA), Vornado Realty Trust (NYSE:VNO)
On Wednesday shares of Athersys, Inc. (NASDAQ:ATHX) closed at $2.63. Company’s sales growth for last 5 years was -6.20% and EPS growth for next 5 years is recorded as 28.00%. On 8 April, Athersys, Inc. (NASDAQ:ATHX) announced that Dr. David Hess, a stroke specialist and Chairman of the Department of Neurology at the Medical College…
-
Market Movers: JPMorgan Chase & Co. (NYSE:JPM), LoJack Corporation (NASDAQ:LOJN), PEDEVCO Corp. (NYSEMKT:PED), Akebia Therapeutics (NASDAQ:AKBA), Mesabi Trust (NYSE:MSB)
On Tuesday shares of JPMorgan Chase & Co. (NYSE:JPM) closed at $63.04. Company’s sales growth for last 5 years was -4.90% and EPS growth for next 5 years is recorded as 8.15%. U.S. stocks traded lower Tuesday despite investment bank JPMorgan Chase & Co. (NYSE:JPM) and mortgage lender Wells Fargo & Co. posting quarterly earnings…
-
Top Wall Street Stories: JetBlue Airways (NASDAQ:JBLU), Akebia Therapeutics (NASDAQ:AKBA), Ruckus Wireless (NYSE:RKUS), Columbia Laboratories (NASDAQ:CBRX), Central Garden & Pet (NASDAQ:CENT)
On Thursday shares of JetBlue Airways Corporation (NASDAQ:JBLU) closed at $18.52. Company’s sales growth for last 5 years was 12.10% and EPS growth for next 5 years is recorded as 42.70%. JetBlue Airways Corporation (NASDAQ:JBLU) will reduce its seasonal flights out of Long Beach Airport when its summer schedule goes into effect, although the airline…
-
Best Stocks: Akebia Therapeutics (NASDAQ:AKBA), Himax Technologies (ADR) (NASDAQ:HIMX), Discover Financial Services (NYSE:DFS), Groupon (NASDAQ:GRPN), Gilead Sciences Inc. (NASDAQ:GILD)
On Tuesday shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) closed at $12.82. Akebia Therapeutics Inc. (NASDAQ:AKBA) presented mid-stage trial data today not only indicating that its anemia drug helps restore hemoglobin levels, but confirming that it does so in a safe and controlled manner. The Phase 2b trial of 210 patients measured hemoglobin in non-dialysis patients…
-
Big Movers in Focus: Akebia Therapeutics (NASDAQ:AKBA), Novogen Limited (NASDAQ:NVGN), Bristow Group (NYSE:BRS), Exelon Corporation (NYSE:EXC), Meru Networks (NASDAQ:MERU)
Akebia Therapeutics, Inc. (NASDAQ:AKBA) reported a net loss and a net loss applicable to common stockholders of $10.4 million, or ($0.52) per share, for the fourth quarter of 2014. Net loss applicable to common stockholders for the fourth quarter of 2013, which includes accretion on preferred stock of $3.0 million, was $9.0 million or ($13.92)…
-
Investor’s Choice: Akebia Therapeutics (NASDAQ:AKBA), Fifth Third Bancorp (NASDAQ:FITB), BSQUARE Corp. (NASDAQ:BSQR), Pointer Telocation (NASDAQ:PNTR), Hormel Foods Corporation (NYSE:HRL)
Akebia Therapeutics Inc (NASDAQ:AKBA) VP General Counsel & Secretary Hadas Nicole R. had sold 1,715 shares worth of $19,654 in a transaction dated January 2, 2015. In this transaction, 1,715 shares were sold at $11.46 per share. On Friday shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) closed at $10.83. On 12 January Fifth Third Bancorp (NASDAQ:FITB)…
-
Hot Runners: Seventy Seven Energy Inc. (NYSE:SSE), Horizon Pharma plc (NASDAQ:HZNP), Canadian Pacific Railway Limited (NYSE:CP), Akebia Therapeutics (NASDAQ:AKBA), Procera Networks (NASDAQ:PKT)
Director of Seventy Seven Energy Inc. (NYSE:SSE) Alexander Bob G had purchased shares worth of $30,900 in a transaction dated on December 5, 2014. A total of 5,000 shares were purchased at a price of $6.18 per share. On Friday shares of Seventy Seven Energy Inc. (NYSE:SSE) closed at $4.52. On 12 January Horizon Pharma…